#BEGIN_DRUGCARD DB03148

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
40730

# Chemical_Formula:
C11H17N5O9P2

# Chemical_IUPAC_Name:
[({[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)methyl]phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Enzyme Inhibitors

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Phosphomethylphosphonic Acid Adenosyl Ester

# HET_ID:
A12

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C11H17N5O9P2/c12-9-6-10(14-2-13-9)16(3-15-6)11-8(18)7(17)5(25-11)1-24-27(22,23)4-26(19,20)21/h2-3,5,7-8,11,17-18H,1,4H2,(H,22,23)(H2,12,13,14)(H2,19,20,21)/t5-,7-,8+,11+/m0/s1

# InChI_Key:
InChIKey=OLCWZBFDIYXLAA-WOIOKPISSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3148

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
425.2283

# Molecular_Weight_Mono:
425.050150191

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1DKU

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.9

# Predicted_LogS:
-2.1

# Predicted_Water_Solubility:
3.36e+00 g/l

# Primary_Accession_No:
DB03148

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936584

# PubChem_Substance_ID:
46508257

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00363
EXPT00533

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@@](O)(=O)CP(O)(O)=O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:57 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X16518

# Drug_Target_1_GenBank_ID_Protein:
40218

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
prs

# Drug_Target_1_Gene_Sequence:
>954 bp
ATGTCTAATCAATACGGAGATAAGAATTTAAAGATTTTTTCTTTGAATTCGAATCCAGAG
CTTGCAAAAGAAATCGCAGATATAGTTGGAGTTCAATTAGGGAAATGTTCTGTCACAAGA
TTTAGTGACGGGGAAGTCCAAATTAATATCGAAGAAAGTATTCGCGGATGTGATTGTTAC
ATCATCCAGTCTACAAGTGACCCCGTTAACGAGCATATTATGGAACTGCTGATTATGGTA
GATGCGTTAAAACGCGCTTCTGCAAAAACGATTAACATTGTTATTCCTTATTACGGTTAT
GCGCGTCAAGACAGAAAAGCAAGATCCCGTGAGCCAATCACAGCTAAACTTTTCGCTAAC
CTGCTTGAAACAGCCGGTGCGACTCGTGTGATTGCACTTGACCTGCATGCGCCGCAAATT
CAAGGATTCTTTGATATACCGATTGACCACTTAATGGGTGTTCCGATTTTAGGAGAATAT
TTTGAAGGCAAAAATCTTGAAGATATCGTCATTGTTTCACCAGACCATGGCGGTGTGACA
CGTGCCCGCAAACTGGCTGACCGACTAAAAGCGCCAATTGCGATTATCGATAAACGCCGT
CCGCGTCCAAACGTGGCGGAAGTCATGAATATTGTAGGTAACATCGAAGGGAAGACTGCT
ATCCTCATCGATGACATTATTGATACTGCAGGTACGATTACACTTGCTGCTAATGCGCTC
GTTGAAAACGGAGCGAAAGAAGTATATGCATGCTGTACACACCCTGTACTATCAGGCCCT
GCGGTTGAACGGATTAATAATTCAACAATTAAAGAGCTTGTTGTGACAAACAGCATCAAG
CTTCCTGAAGAAAAGAAAATTGAACGCTTTAAGCAGCTTTCAGTCGGACCGCTTCTGGCC
GAAGCGATTATTCGCGTTCATGAGCAGCAATCAGTCAGCTATCTGTTCAGCTAA

# Drug_Target_1_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_1_General_References:
10742175	Eriksen TA, Kadziola A, Bentsen AK, Harlow KW, Larsen S: Structural basis for the function of Bacillus subtilis phosphoribosyl-pyrophosphate synthetase. Nat Struct Biol. 2000 Apr;7(4):303-8.
2555671	Nilsson D, Hove-Jensen B, Arnvig K: Primary structure of the tms and prs genes of Bacillus subtilis. Mol Gen Genet. 1989 Sep;218(3):565-71.
7584024	Ogasawara N, Nakai S, Yoshikawa H: Systematic sequencing of the 180 kilobase region of the Bacillus subtilis chromosome containing the replication origin. DNA Res. 1994;1(1):1-14.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3047

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
34869

# Drug_Target_1_Name:
Ribose-phosphate pyrophosphokinase

# Drug_Target_1_Number_of_Residues:
317

# Drug_Target_1_PDB_ID:
1IBS

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00156	Pribosyltran

# Drug_Target_1_Protein_Sequence:
>Ribose-phosphate pyrophosphokinase
MSNQYGDKNLKIFSLNSNPELAKEIADIVGVQLGKCSVTRFSDGEVQINIEESIRGCDCY
IIQSTSDPVNEHIMELLIMVDALKRASAKTINIVIPYYGYARQDRKARSREPITAKLFAN
LLETAGATRVIALDLHAPQIQGFFDIPIDHLMGVPILGEYFEGKNLEDIVIVSPDHGGVT
RARKLADRLKAPIAIIDKRRPRPNVAEVMNIVGNIEGKTAILIDDIIDTAGTITLAANAL
VENGAKEVYACCTHPVLSGPAVERINNSTIKELVVTNSIKLPEEKKIERFKQLSVGPLLA
EAIIRVHEQQSVSYLFS

# Drug_Target_1_Reaction:
ATP + D-ribose 5-phosphate = AMP + 5-phospho-alpha-D-ribose 1-diphosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
ATP + D-ribose 5-phosphate = AMP + 5-phospho- alpha-D-ribose 1-diphosphate

# Drug_Target_1_SwissProt_ID:
P14193

# Drug_Target_1_SwissProt_Name:
KPRS_BACSU

# Drug_Target_1_Synonyms:
EC 2.7.6.1
P-Rib-PP synthetase
PRPP synthetase
Phosphoribosyl pyrophosphate synthetase
RPPK

# Drug_Target_1_Theoretical_pI:
6.26

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Nucleus and mitochondria

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
Not Available

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
Not Available

# Drug_Target_2_Gene_Sequence:
>Example: Dickerson dodecamer
CGCGAATTCGCG

# Drug_Target_2_General_Function:
Biological information storage and information transfer

# Drug_Target_2_General_References:
1234	Nadeau D, Marchand C: Change in the kinetics of sulphacetamide tissue distribution in Walker tumor-bearing rats. Drug Metab Dispos. 1975 Nov-Dec;3(6):565-76.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
874

# Drug_Target_2_Locus:
All loci

# Drug_Target_2_Molecular_Weight:
7656 (double strand)

# Drug_Target_2_Name:
DNA

# Drug_Target_2_Number_of_Residues:
0

# Drug_Target_2_PDB_ID:
1BNA

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
Not Available

# Drug_Target_2_Protein_Sequence:
Not Available

# Drug_Target_2_Reaction:
DNA + DNA polymerase + nNTP = 2 DNA + nNDP; DNA + RNA polymerase + NTP = mRNA + nNDP

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
DNA is the molecule of heredity, as it is responsible for the genetic propagation of most inherited traits. It is a polynucleic acid that carries genetic information on cell growth, division, and function. DNA consists of two long strands of nucleotides twisted into a double helix and held together by hydrogen bonds. The sequence of nucleotides determines hereditary characteristics. Each strand serves as the template for subsequent DNA replication and as a template for mRNA production, leading to protein synthesis via ribosomes.

# Drug_Target_2_SwissProt_ID:
Not Available

# Drug_Target_2_SwissProt_Name:
Not Available

# Drug_Target_2_Synonyms:
Deoxyribonucleic acid

# Drug_Target_2_Theoretical_pI:
Not Available

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
Not Available

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
BX842577

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
MT1739

# Drug_Target_3_Gene_Sequence:
>624 bp
GTGGCTGAGCATGATTTCGAGACGATATCGTCGGAAACCTTGCATACGGGAGCCATTTTC
GCATTACGTCGGGACCAGGTGCGGATGCCTGGTGGGGGTATTGTGACGCGTGAGGTCGTC
GAGCACTTCGGTGCCGTAGCCATTGTGGCGATGGACGACAACGGCAACATCCCGATGGTT
TATCAGTACCGCCACACCTATGGTCGGCGGCTTTGGGAACTGCCCGCGGGGTTGCTCGAC
GTCGCTGGGGAGCCACCTCATCTCACGGCCGCCCGGGAGCTGCGGGAGGAGGTCGGGCTG
CAAGCCAGCACCTGGCAGGTGCTGGTCGATCTGGACACCGCGCCGGGCTTCAGCGACGAA
TCGGTGCGGGTCTATCTGGCCACCGGACTGCGCGAGGTGGGCCGGCCCGAAGCCCATCAC
GAAGAAGCCGACATGACGATGGGGTGGTATCCCATTGCCGAAGCGGCTCGCCGGGTGCTG
CGTGGCGAAATCGTCAATTCCATTGCCATTGCCGGTGTTTTGGCCGTGCACGCGGTGACG
ACCGGGTTCGCCCAGCCACGCCCACTCGATACCGAATGGATCGACAGGCCAACGGCGTTC
GCCGCGCGGAGAGCCGAGCGATGA

# Drug_Target_3_General_Function:
Involved in hydrolase activity

# Drug_Target_3_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
4555

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
22893

# Drug_Target_3_Name:
Hypothetical protein

# Drug_Target_3_Number_of_Residues:
207

# Drug_Target_3_PDB_ID:
1MR2

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00293	NUDIX

# Drug_Target_3_Protein_Sequence:
>Hypothetical protein
MAEHDFETISSETLHTGAIFALRRDQVRMPGGGIVTREVVEHFGAVAIVAMDDNGNIPMV
YQYRHTYGRRLWELPAGLLDVAGEPPHLTAARELREEVGLQASTWQVLVDLDTAPGFSDE
SVRVYLATGLREVGRPEAHHEEADMTMGWYPIAEAARRVLRGEIVNSIAIAGVLAVHAVT
TGFAQPRPLDTEWIDRPTAFAARRAER

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Not Available

# Drug_Target_3_SwissProt_ID:
O33199

# Drug_Target_3_SwissProt_Name:
O33199_MYCTU

# Drug_Target_3_Synonyms:
MutT/nudix family protein

# Drug_Target_3_Theoretical_pI:
5.12

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Periplasm

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
Not Available

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
X03895

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
ushA

# Drug_Target_4_Gene_Sequence:
>1653 bp
ATGAAATTATTGCAGCGGGGCGTGGCGTTAGCGCTGTTAACCACATTTACACTGGCGAGT
GAAACTGCTCTGGCGTATGAGCAGGATAAAACCTACAAAATTACAGTTCTGCATACCAAT
GATCATCATGGGCATTTTTGGCGCAATGAATATGGCGAATATGGTCTGGCGGCGCAAAAA
ACGCTGGTGGATGGTATCCGCAAAGAGGTTGCGGCTGAAGGCGGTAGCGTGCTGCTACTT
TCCGGTGGCGACATTAACACTGGCGTGCCCGAGTCTGACTTACAGGATGCCGAACCTGAT
TTTCGCGGTATGAATCTGGTGGGCTATGACGCGATGGCGATCGGTAATCATGAATTTGAT
AATCCGCTCACCGTATTACGCCAGCAGGAAAAGTGGGCCAAGTTCCCGTTGCTTTCCGCG
AATATCTACCAGAAAAGTACTGGCGAGCGCCTGTTTAAACCGTGGGCGCTGTTTAAGCGT
CAGGATCTGAAAATTGCCGTTATTGGGCTGACAACCGATGACACAGCAAAAATTGGTAAC
CCGGAATACTTCACTGATATCGAATTTCGTAAGCCCGCCGATGAAGCGAAGCTGGTGATT
CAGGAGCTGCAACAGACAGAAAAGCCAGACATTATTATCGCGGCGACCCATATGGGGCAT
TACGATAATGGTGAGCACGGCTCTAACGCACCGGGCGATGTGGAGATGGCACGCGCGCTG
CCTGCCGGATCGCTGGCGATGATCGTCGGTGGTCACTCGCAAGATACGGTCTGCATGGCG
GCAGAAAACAAAAAACAGGTCGATTACGTGCCGGGTACGCCATGCAAACCAGATCAACAA
AACGGCATCTGGATTGTGCAGGCGCATGAGTGGGGCAAATACGTGGGACGGGCTGATTTT
GAGTTTCGTAATGGCGAAATGAAAATGGTTAACTACCAGCTGATTCCGGTGAACCTGAAG
AAGAAAGTGACCTGGGAAGACGGGAAAAGCGAGCGCGTGCTTTACACTCCTGAAATCGCT
GAAAACCAGCAAATGATCTCGCTGTTATCACCGTTCCAGAACAAAGGCAAAGCGCAGCTG
GAAGTGAAAATAGGCGAAACCAATGGTCGTCTGGAAGGCGATCGTGACAAAGTGCGTTTT
GTACAGACCAATATGGGGCGGTTGATTCTGGCAGCCCAAATGGATCGCACTGGTGCCGAC
TTTGCGGTGATGAGCGGAGGCGGAATTCGTGATTCTATCGAAGCAGGCGATATCAGCTAT
AAAAACGTGCTGAAAGTGCAGCCATTCGGCAATGTGGTGGTGTATGCCGACATGACCGGT
AAAGAGGTGATTGATTACCTGACCGCCGTCGCGCAGATGAAGCCAGATTCAGGTGCCTAC
CCGCAATTTGCCAACGTTAGCTTTGTGGCGAAAGACGGCAAACTGAACGACCTTAAAATC
AAAGGCGAACCGGTCGATCCGGCGAAAACTTACCGTATGGCGACATTAAACTTCAATGCC
ACCGGCGGTGATGGATATCCGCGCCTTGATAACAAACCGGGCTATGTGAATACCGGCTTT
ATTGATGCCGAAGTGCTGAAAGCGTATATCCAGAAAAGCTCGCCGCTGGATGTGAGTGTT
TATGAACCGAAAGGTGAGGTGAGCTGGCAGTAA

# Drug_Target_4_General_Function:
Involved in hydrolase activity

# Drug_Target_4_General_References:
10331872	Knofel T, Strater N: X-ray structure of the Escherichia coli periplasmic 5'-nucleotidase containing a dimetal catalytic site. Nat Struct Biol. 1999 May;6(5):448-53.
11491293	Knofel T, Strater N: Mechanism of hydrolysis of phosphate esters by the dimetal center of 5'-nucleotidase based on crystal structures. J Mol Biol. 2001 May 25;309(1):239-54.
11491294	Knofel T, Strater N: E. coli 5'-nucleotidase undergoes a hinge-bending domain rotation resembling a ball-and-socket motion. J Mol Biol. 2001 May 25;309(1):255-66.
3012467	Burns DM, Beacham IR: Nucleotide sequence and transcriptional analysis of the E. coli ushA gene, encoding periplasmic UDP-sugar hydrolase (5'-nucleotidase): regulation of the ushA gene, and the signal sequence of its encoded protein product. Nucleic Acids Res. 1986 May 27;14(10):4325-42.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
5123

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
60825

# Drug_Target_4_Name:
Protein ushA

# Drug_Target_4_Number_of_Residues:
550

# Drug_Target_4_PDB_ID:
2USH

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00149	Metallophos
PF02872	5_nucleotid_C

# Drug_Target_4_Protein_Sequence:
>Protein ushA
MKLLQRGVALALLTTFTLASETALAYEQDKTYKITVLHTNDHHGHFWRNEYGEYGLAAQK
TLVDGIRKEVAAEGGSVLLLSGGDINTGVPESDLQDAEPDFRGMNLVGYDAMAIGNHEFD
NPLTVLRQQEKWAKFPLLSANIYQKSTGERLFKPWALFKRQDLKIAVIGLTTDDTAKIGN
PEYFTDIEFRKPADEAKLVIQELQQTEKPDIIIAATHMGHYDNGEHGSNAPGDVEMARAL
PAGSLAMIVGGHSQDPVCMAAENKKQVDYVPGTPCKPDQQNGIWIVQAHEWGKYVGRADF
EFRNGEMKMVNYQLIPVNLKKKVTWEDGKSERVLYTPEIAENQQMISLLSPFQNKGKAQL
EVKIGETNGRLEGDRDKVRFVQTNMGRLILAAQMDRTGADFAVMSGGGIRDSIEAGDISY
KNVLKVQPFGNVVVYADMTGKEVIDYLTAVAQMKPDSGAYPQFANVSFVAKDGKLNDLKI
KGEPVDPAKTYRMATLNFNATGGDGYPRLDNKPGYVNTGFIDAEVLKAYIQKSSPLDVSV
YEPKGEVSWQ

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
1-25

# Drug_Target_4_Specific_Function:
Degradation of external UDP-glucose to uridine monophosphate and glucose-1-phosphate, which can then be used by the cell

# Drug_Target_4_SwissProt_ID:
P07024

# Drug_Target_4_SwissProt_Name:
USHA_ECOLI

# Drug_Target_4_Synonyms:
Protein ushA precursor

# Drug_Target_4_Theoretical_pI:
5.41

# Drug_Target_4_Transmembrane_Regions:
None

#END_DRUGCARD DB03148
